This is a $299,896 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Radiabeam Technologies, LLC, a small business manufacturer, for the development of laser-driven proton and carbon therapy systems. The contract has no set-aside designation. Radiabeam Technologies is a leading provider of advanced accelerator technologies, specializing in the design, manufacturing, and validation of particle accelerator components and systems. Through...
This is a $1,558,088.00 definitive, firm-fixed-price contract awarded by the National Nuclear Security Administration (NNSA), a component of the U.S. Department of Energy, to Radiabeam Systems, LLC, a for-profit limited liability company. The contract is for SBIR Phase III work on the development of novel, low-cost medical accelerator designs for use in challenging environments. This is an unset-aside contract to provide safe, high-throughput, self-contained irradiator systems. Radiabeam...
<p>This is a $2,300,000.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Cancer Targeted Technology LLC, a small business located in Pullman, Washington. The contract is for the development of an innovative Prostate-Specific Membrane Antigen (PSMA)-targeted radionuclide therapy for prostate cancer. The contract has a completion date of August 29, 2018. This award represents a set-aside for small businesses.</p>
<p>This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Varian Medical Systems, Inc. for the acquisition of one TRUEBEAM SYSTEM MULTIPLE ENERGY PHOTON AND ELECTRON BEAM LINEAR ACCELERATOR. The contract has a ceiling value of $3,674,389 and a period of performance ending on March 10, 2017. This contract award is not associated with a set-aside program.</p>
This is a $2,372,276.00 firm fixed price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Doseoptics LLC, a for-profit limited liability company. The contract is for Phase I of a Fast Track Small Business Innovation Research (SBIR) project under Topic 461 to develop a "Conformable Scintillator Array for In Vivo Dosimetry During Radiation Therapy (RT)." The award has a period of performance through September 15, 2027. Doseoptics has previously received over...
This $1,999,956.00 firm fixed-price Small Business Innovation Research (SBIR) Phase II contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Tibaray, Inc. - a Bay Area startup that develops particle accelerator systems for cancer treatment. The contract supports the topic "ULTRA-RAID RF-BASED BEAM MONITOR FOR REAL-TIME FLASH BEAM CONTROL" and has a performance period running through September 15, 2026. Tibaray...
The National Cancer Institute awarded a $299,546.00 Firm Fixed Price contract to Woodtoga Holdings Company for the development of a novel electronic particle brachytherapy source. This Small Business set-aside contract has a completion date of September 24, 2014. Brachytherapy is a method of radiation therapy where a radiation source is placed inside or next to the area requiring treatment. This contract supports the National Cancer Institute's research and development efforts to advance...
This $399,617 Firm Fixed Price contract was awarded by the National Cancer Institute (NCI) to Tibaray, Inc., a Bay Area startup that develops particle accelerator systems for cancer treatment. The contract, which is set aside for small businesses, is part of the NCI's Small Business Innovation Research (SBIR) program and funds research and development of ultra-fast dose rate (FLASH) radiation detectors and safety systems. Tibaray, a manufacturer of medical equipment, has previously received...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (NCI) awarded a $249,738.00 firm fixed price purchase order contract to Tesla Engineering LIMITED, a for-profit manufacturer, for the purchase of air cooled magnet and gradient coils with magnet power supply and gradient amplifiers. This sole source acquisition supports the NCI's Center for Cancer Research (CCR) Radiation Biology Branch and was processed under the authority of Federal...
This is a $124,918 firm fixed-price STTR Phase I research and development contract awarded by the Department of Defense's Missile Defense Agency to Radiabeam Technologies, LLC, a small business, for the development of a compact, transportable racetrack cyclotron for heavy-ion radiation testing of electronics. The work will be performed in Santa Monica, CA. Radiabeam Technologies is a provider of particle accelerator components and systems, with experience supporting research programs for...
This is a $203,840 firm-fixed-price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to T Antaya, LLC, doing business as Antaya Science & Technology, for the development of a "COMPACT, LOW-COST, HIGH-INTENSITY SUPERCONDUCTING ISOCHRONOUS CYCLOTRON FOR SPOT BEAM SCANNING PBRT". The contract does not have a set-aside designation and was awarded on September 25, 2013, with an ultimate completion date of June 24, 2014. The contract is for the delivery of a specialized cyclotron device to be used in proton beam radiation therapy (PBRT) applications.